Dabictrel approval has been withdrawn even without debut

Published: 2015-10-12 14:12:43

Updated: 2015-10-12 14:12:43

Hanwha Chemical has voluntarily withdrawn the product approval of ‘Dabictrel(etanercept),’ a Enbrel biosimilar.

Thus, a domestic biosimilar which was approved to be commercialized for the third time has now been disappeared even without a debut in the domestic market.

The Ministry of Food and Drug Safety approved the voluntary withdrawal of ‘Dabictrel Inj 25mg’ applied by Hanwha Chemical on t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.